Rapid Micro Biosystems, Inc.

NasdaqCM RPID

Rapid Micro Biosystems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2024

Rapid Micro Biosystems, Inc. Gross Profit Margin is NA for the Trailing 12 Months (TTM) ending September 30, 2024. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Rapid Micro Biosystems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2022 was -47.45%, a -32.80% change year over year.
  • Rapid Micro Biosystems, Inc. Gross Profit Margin for the Trailing 12 Months (TTM) ending September 30, 2021 was -35.73%.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
SV Wall Street
NasdaqCM: RPID

Rapid Micro Biosystems, Inc.

CEO Mr. Robert G. Spignesi Jr.
IPO Date July 15, 2021
Location United States
Headquarters 1001 Pawtucket Boulevard West
Employees 193
Sector Health Care
Industries
Description

Rapid Micro Biosystems, Inc., a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in North America, Europe, and Asia. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and comprehensive customer support and validation services. Its platform automates and modernizes the manual microbial quality control (MQC) testing workflows for therapeutic modalities, such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company also provides installation and verification, technical training, and support services. Its solutions are used in environmental monitoring, water testing, bioburden, and sterility release testing applications. The company was formerly known as Genomic Profiling Systems, Inc. and changed its name to Rapid Micro Biosystems, Inc. in January 2007. Rapid Micro Biosystems, Inc. was incorporated in 2006 and is headquartered in Lowell, Massachusetts.

Similar companies

AXGN

AxoGen, Inc.

USD 18.21

-0.33%

VVOS

Vivos Therapeutics, Inc.

USD 3.97

1.02%

SRDX

Surmodics, Inc.

USD 34.04

-4.06%

LIVN

LivaNova PLC

USD 49.95

-1.36%

OWLT

Owlet, Inc.

USD 4.46

-3.04%

BVS

Bioventus Inc.

USD 10.68

0.28%

BJDX

Bluejay Diagnostics, Inc.

USD 3.68

-12.80%

ELMD

Electromed, Inc.

USD 34.40

-2.11%

KIDS

OrthoPediatrics Corp.

USD 24.00

-0.58%

RXST

RxSight, Inc.

USD 33.87

3.07%

TMCI

Treace Medical Concepts, Inc.

USD 10.05

0.20%

LUNG

Pulmonx Corporation

USD 5.68

-0.18%

BBLG

Bone Biologics Corporation

USD 1.11

-0.89%

LNSR

LENSAR, Inc.

USD 11.10

2.49%

IRIX

IRIDEX Corporation

USD 1.64

0.00%

OFIX

Orthofix Medical Inc.

USD 18.33

-1.72%

StockViz Staff

February 4, 2025

Any question? Send us an email